Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer (protocol)

Ya Gao; M Liu; L Liu; J Zhang; F Song; J Tian

doi:10.1002/14651858.CD015072

Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer (protocol)

Ya Gao
, M Liu
, L Liu
, J Zhang
, F Song
, J Tian

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

24 Downloads (Pure)

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the efficacy and safety of PD-1 inhibitors or PD-L1 inhibitors plus chemotherapy compared with chemotherapy for people with early triple-negative breast cancer.

Original language	English
Article number	CD015072
Journal	Cochrane Database of Systematic Reviews
Volume	2022
Issue number	9
DOIs	https://doi.org/10.1002/14651858.CD015072
Publication status	Published - 26 Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/14651858.CD015072

Gao_et_al-2022-Cochrane_Database_of_Systematic_ReviewsFinal published version, 179 KB

Cite this

@article{65dd414ec1a640fa8f0655d89ba3ad3b,

title = "Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer (protocol)",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the efficacy and safety of PD-1 inhibitors or PD-L1 inhibitors plus chemotherapy compared with chemotherapy for people with early triple-negative breast cancer.",

author = "Ya Gao and M Liu and L Liu and J Zhang and F Song and J Tian",

year = "2022",

month = sep,

day = "26",

doi = "10.1002/14651858.CD015072",

language = "English",

volume = "2022",

journal = "Cochrane Database of Systematic Reviews",

issn = "1361-6137",

publisher = "Wiley",

number = "9",

}

TY - JOUR

T1 - Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer (protocol)

AU - Gao, Ya

AU - Liu, M

AU - Liu, L

AU - Zhang, J

AU - Song, F

AU - Tian, J

PY - 2022/9/26

Y1 - 2022/9/26

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the efficacy and safety of PD-1 inhibitors or PD-L1 inhibitors plus chemotherapy compared with chemotherapy for people with early triple-negative breast cancer.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the efficacy and safety of PD-1 inhibitors or PD-L1 inhibitors plus chemotherapy compared with chemotherapy for people with early triple-negative breast cancer.

UR - https://www.scopus.com/pages/publications/85139024497

U2 - 10.1002/14651858.CD015072

DO - 10.1002/14651858.CD015072

M3 - Article

SN - 1361-6137

VL - 2022

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 9

M1 - CD015072

ER -

Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer (protocol)

Abstract

UN SDGs

Access to Document

Other files and links

Cite this